VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification

[1]  G. Stone,et al.  Coronary artery calcification: pathogenesis and prognostic implications. , 2014, Journal of the American College of Cardiology.

[2]  J. Jiménez-Moleón,et al.  Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes. , 2012, Diabetes & metabolism.

[3]  D. Berman,et al.  Relationship of coronary artery plaque composition to coronary artery stenosis severity: results from the prospective multicenter ACCURACY trial. , 2011, Atherosclerosis.

[4]  H. Crijns,et al.  Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. , 2011, European heart journal.

[5]  Y. Rais,et al.  Bone Gla Protein Increases HIF-1&agr;–Dependent Glucose Metabolism and Induces Cartilage and Vascular Calcification , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[6]  P. Reitsma,et al.  Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis , 2011, Thrombosis and Haemostasis.

[7]  C. Reutelingsperger,et al.  Role of vitamin K-dependent proteins in the arterial vessel wall , 2011, Hämostaseologie.

[8]  J. J. Rivera,et al.  Association Between High-Sensitivity C-Reactive Protein and Coronary Plaque Subtypes Assessed by 64-Slice Coronary Computed Tomography Angiography in an Asymptomatic Population , 2011, Circulation. Cardiovascular imaging.

[9]  Andrew D. Johnson,et al.  Association of Single Nucleotide Polymorphisms on Chromosome 9p21.3 With Platelet Reactivity: A Potential Mechanism for Increased Vascular Disease , 2010, Circulation. Cardiovascular genetics.

[10]  Thomas W. Mühleisen,et al.  Coronary Artery Calcification and Its Relationship to Validated Genetic Variants for Diabetes Mellitus Assessed in the Heinz Nixdorf Recall Cohort , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[11]  M. Daemen,et al.  Early atherosclerosis exhibits an enhanced procoagulant state. , 2010, Circulation.

[12]  J. Labreuche,et al.  VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis. , 2010, Thrombosis research.

[13]  R. Dai,et al.  What is the best contrast injection protocol for 64-row multi-detector cardiac computed tomography? , 2010, European journal of radiology.

[14]  J. V. van Engelshoven,et al.  Calcium scores and matrix Gla protein levels: association with vitamin K status , 2010, European journal of clinical investigation.

[15]  A. Komar.  Single Nucleotide Polymorphisms , 2009, Methods in Molecular Biology™.

[16]  A. Radbruch,et al.  Single nucleotide polymorphisms in the VKORC1 gene and the risk of stroke in the Southern German population , 2008, Thrombosis and Haemostasis.

[17]  M. Loriot,et al.  No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease , 2008, Thrombosis and Haemostasis.

[18]  A. Hofman,et al.  Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Polymorphism and Aortic Calcification: The Rotterdam Study , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Timur Shtatland,et al.  Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.

[20]  L. Hindorff,et al.  Common VKORC1 variants are not associated with arterial or venous thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.

[21]  P. Engelhardt,et al.  Accuracy of 64-Slice Computed Tomography versus Invasive Coronary Angiography in Diagnosing Coronary Artery Disease , 2007 .

[22]  Jonathan G Goldin,et al.  Assessment of Coronary Artery Disease by Cardiac Computed Tomography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiolog , 2006, Circulation.

[23]  Yibo Wang,et al.  VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection) , 2006, Circulation.

[24]  Konstantin Nikolaou,et al.  Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. , 2006, Journal of the American College of Cardiology.

[25]  C. Esmon.  The interactions between inflammation and coagulation , 2005, British journal of haematology.

[26]  D. Stafford.  The vitamin K cycle , 2005, Journal of thrombosis and haemostasis : JTH.

[27]  M. Charng,et al.  A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. , 2005, Human molecular genetics.

[28]  O. Florey,et al.  Proinflammatory Activation of Macrophages by Basic Calcium Phosphate Crystals via Protein Kinase C and MAP Kinase Pathways: A Vicious Cycle of Inflammation and Arterial Calcification? , 2005, Circulation research.

[29]  Deborah A Nickerson,et al.  Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. , 2005, The New England journal of medicine.

[30]  Yibo Wang,et al.  Vitamin K Epoxide Reductase: A Protein Involved in Angiogenesis , 2005, Molecular Cancer Research.

[31]  M. Margaglione,et al.  A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. , 2005, Blood.

[32]  T. van der Poll,et al.  Bidirectional Relation Between Inflammation and Coagulation , 2004, Circulation.

[33]  A. Khvorova,et al.  Identification of the gene for vitamin K epoxide reductase , 2004, Nature.

[34]  Andreas Fregin,et al.  Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 , 2004, Nature.

[35]  C. Esmon.  Inflammation and thrombosis , 2003, Journal of thrombosis and haemostasis : JTH.

[36]  M. Jochims,et al.  MRI assessment of coronary artery disease. , 1999, Rays.

[37]  NingXu,et al.  Association of Vitamin K–Dependent Coagulation Proteins and C4b Binding Protein With Triglyceride-Rich Lipoproteins of Human Plasma , 1998 .

[38]  B. Dahlbäck,et al.  Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[39]  W. Lawson,et al.  Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease. , 1993, The Journal of laboratory and clinical medicine.

[40]  正昭 荒川,et al.  血液透析患者の血清bone Gla-protein , 1988 .

[41]  P. Fernlund,et al.  Vitamin K dependent modifications of glutamic acid residues in prothrombin. , 1974, Proceedings of the National Academy of Sciences of the United States of America.